Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 2Phase 3 1

Status

Completed 5Withdrawn 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6Genitourinary 1

Conditions

Breast Neoplasms 6

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Alloderm × Breast × Clear all
NCT00956384 2024-12-05

AllodermRCT

University Health Network, Toronto

Phase NA Completed
198 enrolled 9 charts
Breast

Breast Neoplasms

NCT00639106 2018-10-03

Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
70 enrolled
Breast

Breast Neoplasms

NCT02372305 2018-07-18

Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery

University of Arkansas

Phase 4 Withdrawn
Breast

Breast Neoplasms

NCT00872859 2017-05-18

The BREASTrial:Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial

University of Utah

Phase 4 Completed
128 enrolled
Breast

Breast Neoplasms

NCT01561287 2016-05-11

A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction

University of Kentucky

Phase 4 Completed
48 enrolled
Breast

Breast Neoplasms

NCT01027637 2013-09-06

Regenerative Tissue Matrix for Breast Reconstruction

Henry Ford Health System

Phase NA Completed
33 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡